Ambrisentan
- Strength
- 10 mg/1
- Form
- Tablet, Film Coated
- Class
- Endothelin Receptor Antagonist
Quallent Pharmaceuticals Health LLC
Listed by Actavis Pharma, Inc.
| Dosage form | Tablet, Film Coated |
|---|---|
| Route | Oral |
| Drug class | Endothelin Receptor Antagonist |
| Approval route | ANDA — approved generic |
| NDC code | 0591-2405 |
| FDA application | ANDA208252 |
| RxNorm concept | 722116 |
| Package sizes listed | 1 |
| Marketed since | April 2019 |
Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.
Quallent Pharmaceuticals Health LLC
A-S Medication Solutions
Aurobindo Pharma Limited
Zydus Pharmaceuticals USA Inc.
Zydus Lifesciences Limited
Sun Pharmaceutical Industries, Inc.
Apotex Corp.
Aurobindo Pharma Limited
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.
Please don't share card details in chat.